Market Movers

Humana Inc.’s Stock Price Soars to $269.78, Marking a Robust Increase of 2.03%

Humana Inc. (HUM)

269.78 USD +5.37 (+2.03%) Volume: 1.63M

Humana Inc.’s stock price soars at 269.78 USD, witnessing a positive shift of +2.03% this trading session with a robust trading volume of 1.63M, and an impressive YTD increase of +6.33%, reflecting a strong market performance.


Latest developments on Humana Inc.

Humana Inc. (NYSE:HUM) has seen a surge in stock price movements today as various financial institutions adjust their holdings in the company. Icon and Humana are collaborating to enhance senior healthcare with integrated specialty care, driving investor interest. AlphaQuest LLC, Swiss National Bank, and other major players have made significant changes to their stakes in Humana Inc., with some trimming positions while others acquiring shares. This flurry of activity in the stock market reflects the growing focus on Humana’s role in the healthcare sector, with options activity also drawing attention. As investors continue to monitor these developments, the future outlook for Humana remains dynamic and promising.


Humana Inc. on Smartkarma

According to Value Investors Club, Humana Inc provides Medicare Advantage plans to around 6 million members, offering government health insurance for seniors through private insurers. The research report, published 3 months ago, leans bullish on the company, highlighting its focus on value-based care relationships with providers and preventative treatment. This information is sourced from publicly available sources and aims to provide general informational purposes about Humana Inc.

Baptista Research suggests that Humana Inc could be the next major acquisition target for Cigna, one of its rivals in the U.S. health insurance market. Recent reports indicate that informal talks between Cigna and Humana have resumed, although still in the early stages. The research report leans bullish on Humana Inc and discusses how changes in the government’s Medicare plan ratings have impacted the company’s performance. This analysis provides insights into the potential future of Humana Inc within the health insurance industry.


A look at Humana Inc. Smart Scores

FactorScoreMagnitude
Value4
Dividend4
Growth3
Resilience3
Momentum4
OVERALL SMART SCORE3.6

Smart Score is a compound score for the Company indicating its overall outlook. It is derived by taking an equally weighted average of underlying Factor scores computed by Smartkarma

Humana Inc. shows promising long-term prospects based on its Smartkarma Smart Scores. With high scores in Value, Dividend, and Momentum, the company appears to be well-positioned for growth and stability. While the Growth and Resilience scores are slightly lower, Humana’s strong performance in other areas suggests a positive outlook for the company in the future.

As a managed health care company serving members in the US and Puerto Rico, Humana Inc. offers a range of health care services through various plans and products. With a focus on coordinated care and serving different customer groups, including employer groups and individuals, Humana has established itself as a key player in the healthcare industry. The company’s solid Smart Scores indicate a strong overall outlook, showcasing its potential for continued success and growth in the market.


Disclaimer: This article by Smartkarma is general in nature and based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. Note that our articles may not factor in the latest price-sensitive company announcements or qualitative material.
While all reasonable care has been taken in the preparation, Smartkarma makes no assurance about the accuracy of any generated data or content. All content is indicative only and should be independently checked for accuracy and confirmed before use. Smartkarma accepts no responsibility for any loss or damage caused as a result of any inaccuracy or error within the Lab online tools or generated data.
Have feedback on this article? Concerned about the content? Get in touch with us directly.


 

πŸ’‘ Before it’s here, it’s on Smartkarma

Sign Up for Free

The Smartkarma Preview Pass is your entry to the Independent Investment Research Network

  • βœ“ Unlimited Research Summaries
  • βœ“ Personalised Alerts
  • βœ“ Custom Watchlists
  • βœ“ Company Analytics and News
  • βœ“ Events & Webinars